Product NDC: | 0019-N602 |
Proprietary Name: | SODIUM IODIDE I 123 |
Non Proprietary Name: | sodium iodide i 123 |
Active Ingredient(s): | 200 uCi/1 & nbsp; sodium iodide i 123 |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, GELATIN COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0019-N602 |
Labeler Name: | Mallinckrodt Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA071910 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070411 |
Package NDC: | 0019-N602-20 |
Package Description: | 1 BOTTLE in 1 CAN (0019-N602-20) > 1 CAPSULE, GELATIN COATED in 1 BOTTLE |
NDC Code | 0019-N602-20 |
Proprietary Name | SODIUM IODIDE I 123 |
Package Description | 1 BOTTLE in 1 CAN (0019-N602-20) > 1 CAPSULE, GELATIN COATED in 1 BOTTLE |
Product NDC | 0019-N602 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sodium iodide i 123 |
Dosage Form Name | CAPSULE, GELATIN COATED |
Route Name | ORAL |
Start Marketing Date | 20070411 |
Marketing Category Name | ANDA |
Labeler Name | Mallinckrodt Inc. |
Substance Name | SODIUM IODIDE I-123 |
Strength Number | 200 |
Strength Unit | uCi/1 |
Pharmaceutical Classes | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |